Altido Therapeutics

Altido Therapeutics is a startup based in the United States. Brouky classifies it under Healthcare & Life Sciences.

Altido Therapeutics is a clinical-stage biotechnology company developing a novel CAR-TEAM T cell-based immunotherapy platform that genetically engineers a patient’s T cells to attack difficult-to-treat solid tumors such as glioblastoma by targeting multiple tumor antigens simultaneously.